Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis

Johanna Jefferies1, Leena Nieminen, Lea-Ann Kirkham

  • 1Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

Journal of Bacteriology
|October 31, 2006
PubMed

Insights

Streptococcus mitis produces a novel toxin, mitilysin, distinct from pneumolysin. This finding has implications for pneumococcal disease vaccines and therapies due to potential genetic exchange.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Bacterial Pathogenesis

Background:

  • Cholesterol-dependent cytolysins are key virulence factors in many bacterial pathogens.
  • Streptococcus pneumoniae causes significant human disease, and its toxin pneumolysin is a vaccine target.
  • The genetic and functional relationship between S. pneumoniae and Streptococcus mitis is not fully understood.

Purpose of the Study:

  • To identify and characterize novel toxins produced by Streptococcus mitis.
  • To investigate the genetic and functional relationship between mitilysin and pneumolysin.
  • To assess the implications of mitilysin discovery for pneumococcal disease research.

Main Methods:

  • Detection and isolation of mitilysin from Streptococcus mitis.
  • Gene sequencing of mitilysin and comparison with pneumolysin gene.
  • Analysis of mitilysin secretion and functional assays (ELISA, neutralization).
  • Monoclonal antibody cross-reactivity studies.

Main Results:

  • A novel cholesterol-dependent cytolysin, mitilysin, was identified in Streptococcus mitis isolates.
  • Mitilysin exhibits 15 amino acid substitutions compared to pneumolysin.
  • Mitilysin is extracellularly released by S. mitis.
  • Some mitilysin alleles are not recognized by pneumolysin-specific antibodies, and one isolate may produce an additional hemolytic toxin.

Conclusions:

  • Streptococcus mitis produces mitilysin, a distinct cytolysin with implications for pneumococcal research.
  • Genetic exchange between S. mitis and S. pneumoniae could impact the efficacy of pneumolysin-based vaccines and therapies.
  • Further research is needed to understand the role of mitilysin in pathogenesis and its interaction with the host immune system.

Related Concept Videos